Production (Stage)
Palvella Therapeutics, Inc.
PVLA
$25.40
$1.918.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 75.63M | 83.60M | 14.21M | 14.54M | 7.35M |
| Total Receivables | 1.98M | 2.34M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.84M | 2.30M | 441.00K | 307.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 1.67M | 500.00K | -- |
| Total Current Assets | 79.44M | 88.23M | 16.32M | 15.34M | -- |
|
|
|||||
| Total Current Assets | 79.44M | 88.23M | 16.32M | 15.34M | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 79.44M | 88.23M | 16.32M | 15.34M | -- |
|
|
|||||
| Total Accounts Payable | 4.44M | 4.59M | 3.13M | 1.45M | -- |
| Total Accrued Expenses | 1.74M | 4.29M | 4.22M | 2.72M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2.80M | 3.17M | 282.00K | 231.00K | -- |
| Total Other Current Liabilities | 2.80M | 3.17M | 282.00K | 231.00K | -- |
| Total Current Liabilities | 8.98M | 12.04M | 7.64M | 4.40M | -- |
|
|
|||||
| Total Current Liabilities | 8.98M | 12.04M | 7.64M | 4.40M | -- |
| Long-Term Debt | 13.16M | 11.94M | 24.07M | 19.83M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.72M | 1.65M | 1.42M | 1.34M | -- |
| Total Liabilities | 23.86M | 25.63M | 33.12M | 25.57M | -- |
|
|
|||||
| Common Stock & APIC | 157.50M | 156.34M | 2.38M | 2.18M | -- |
| Retained Earnings | -101.92M | -93.74M | -89.78M | -83.01M | -- |
| Treasury Stock & Other | -3.00K | 3.00K | -- | -- | -- |
| Total Common Equity | 55.58M | 62.61M | -87.40M | -80.83M | -74.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 70.60M | 70.60M | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 70.60M | 70.60M | 70.60M |
|
|
|||||
| Total Common Equity | 55.58M | 62.61M | -87.40M | -80.83M | -74.48M |
| Total Preferred Equity | -- | -- | 70.60M | 70.60M | 70.60M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 55.58M | 62.61M | -16.80M | -10.23M | -3.88M |
|
|
|||||